Canada’s review of Pfizer’s COVID-19 vaccine for young children to completed within 2 weeks – health official

OTTAWA (Reuters) – Canada’s review of Pfizer/Biontech’s COVID-19 vaccine for children aged 5 to 11 years should be completed in 1 to 2 weeks, Health Canada’s chief medical advisor Supriya Sharma said on Friday.

(Reporting by Ismail Shakil in Bengaluru and Steve Scherer in Ottawa)